4/25
08:33 am
eltx
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting [Yahoo! Finance]
Low
Report
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting [Yahoo! Finance]
4/25
08:30 am
eltx
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
Low
Report
Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
4/5
04:30 pm
eltx
Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
Low
Report
Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
3/29
08:30 am
eltx
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
Medium
Report
Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates
3/18
08:00 am
eltx
Elicio Therapeutics Announces $6.0 Million Private Placement Financing
High
Report
Elicio Therapeutics Announces $6.0 Million Private Placement Financing
3/6
08:30 am
eltx
Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
Medium
Report
Elicio Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting
2/5
08:30 am
eltx
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Medium
Report
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference